Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2022 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives

Highlights: Strong business performance despite COVID-19 headwindsRevenue of $160.8 million in the fourth quarter and $690.6 million for the year ended Dec. 31, 2021, up 4% and 24%, respectively...
February 23, 2022 16:30 ET | Source: Myriad Genetics, Inc.

New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test

SALT LAKE CITY, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced today the peer-reviewed journal Psychiatry...
February 16, 2022 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Release Fourth-Quarter 2021 Financial Results on February 24, 2022

SALT LAKE CITY, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its 2021 fourth-quarter earnings conference...
February 14, 2022 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at Two Upcoming Healthcare Conferences

SALT LAKE CITY, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will be presenting at two upcoming healthcare...
January 05, 2022 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference

SALT LAKE CITY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will provide an update on the...
January 04, 2022 16:47 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service

SALT LAKE CITY, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the retirement of Jerry Lanchbury Ph.D....
December 15, 2021 10:47 ET | Source: Myriad Genetics, Inc.

New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey

SALT LAKE CITY, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Now is the time when people start to think of new year’s resolutions to improve their health. For many, the focus is on physical goals like losing...
December 14, 2021 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer

SALT LAKE CITY, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the promotion of Nicole Lambert to chief...
November 23, 2021 07:05 ET | Source: Myriad Genetics, Inc.

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

SALT LAKE CITY, Nov. 23, 2021 (GLOBE NEWSWIRE) -- One of the biggest issues parents of teenagers may face is determining if their child is experiencing a mental health challenge or ordinary “growing...
November 22, 2021 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment

SALT LAKE CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two upcoming poster presentations at the...